John J. Canepa

PathoGenetix, Inc. operates as a commercial-stage developer of an automated system for rapid bacterial identification from complex samples. Its Genome Sequence Scanning technology isolates and analyzes DNA from an enriched biological sample, without the need for a cultured isolate. The firm specializes in food safety, industrial microbiology, and clinical diagnostics and research. The company was founded in 1997 and is headquartered in Watertown, MA.

Winphoria Networks, Inc. manufactures wireless communications equipment used in the cellular telecommunications industry. The company was founded by Murali Aravamudan and Shamim Naqvi on March 15, 2000 and is headquartered in Tewksbury, MA.

Arthur Andersen LLP used to provide accounting services. It was also into consulting services for clients that operate businesses throughout the United States and around the world. Arthur Andersen was founded in 1913 and was headquartered in Chicago, IL.

Asterand Biosciences, Inc. provided stem cell research products. It offered proprietary reagents and tools developed by stem cell scientists. The firm's products included small molecules for pluripotency, self-renewal and differentiation, viral-delivered transcription factors, matrices, cell lines, cytokines, antibodies and transfection reagents. The company was founded by Ian W. Ratcliffe, Stephen M. Chang and Sheng Ding in 2006 and headquartered in Detroit, MI.

Mount Auburn Hospital provides healthcare services. It offers care and treatment for addiction, alcohol abuse, arthritis care, athletic injury, breast health, blood disorders, cancer, and colon and rectal surgery. The company was founded in 1886 and is headquartered in Cambridge, MA.

CareGroup, Inc. provides medical and surgical services. Its health care services include orthopedics, obstetrics, diabetes, and cardiovascular disease. The company was founded on June 22, 1984 and is headquartered in Boston, MA.

Agilis Biotherapeutics LLC operates as a biotechnology company. It focuses on designing and engineering first-in-class DNA-based therapeutics to improve and save the lives of patients affected by life-threatening or fatal rare diseases for which there are no or limited treatment options. The company was founded in 2013 and is headquartered in Cambridge, MA.